A specific mechanism of nonspecific inhibition

被引:500
作者
McGovern, SL
Helfand, BT
Feng, B
Shoichet, BK
机构
[1] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA
[2] Northwestern Univ, Dept Biol Chem & Mol Pharmacol, Chicago, IL 60611 USA
[3] Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL 60611 USA
关键词
D O I
10.1021/jm030266r
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Promiscuous small molecules plague screening libraries and hit lists. Previous work has found that several nonspecific compounds form submicrometer aggregates, and it has been suggested that this aggregate species is responsible for the inhibition of many different enzymes. It is not understood how aggregates inhibit their targets. To address this question, biophysical, kinetic, and microscopy methods were used to study the interaction of promiscuous, aggregate-forming inhibitors with model proteins. By use of centrifugation and gel electrophoresis, aggregates and protein were found to directly interact. This is consistent with a subsequent observation from confocal fluorescence microscopy that aggregates concentrate green fluorescent protein. beta-Lactamase mutants with increased or decreased thermodynamic stability relative to wild-type enzyme were equally inhibited by an aggregate-forming compound, suggesting that denaturation by unfolding was not the primary mechanism of interaction. Instead, visualization by electron microscopy revealed that enzyme associates with the surface of inhibitor aggregates. This association could be reversed or prevented by the addition of Triton X-100. These observations suggest that the aggregates formed by promiscuous compounds reversibly sequester enzyme, resulting in apparent inhibition. They also suggest a simple method to identify or reverse the action of aggregate-based inhibitors, which appear to be widespread.
引用
收藏
页码:4265 / 4272
页数:8
相关论文
共 21 条
[1]   Integration of virtual and high-throughput screening [J].
Bajorath, F .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (11) :882-894
[2]   Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening [J].
Boehm, HJ ;
Boehringer, M ;
Bur, D ;
Gmuender, H ;
Huber, W ;
Klaus, W ;
Kostrewa, D ;
Kuehne, H ;
Luebbers, T ;
Meunier-Keller, N .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (14) :2664-2674
[3]   Protein kinase C erectors bind to multidrug ABC transporters and inhibit their activity [J].
Conseil, G ;
Perez-Victoria, JM ;
Jault, JM ;
Gammaro, F ;
Goffeau, A ;
Hofmann, J ;
Di Pietro, A .
BIOCHEMISTRY, 2001, 40 (08) :2564-2571
[4]   Specificity and mechanism of action of some commonly used protein kinase inhibitors [J].
Davies, SP ;
Reddy, H ;
Caivano, M ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2000, 351 (351) :95-105
[5]   In situ assembly of enzyme inhibitors using extended tethering [J].
Erlanson, DA ;
Lam, JW ;
Wiesmann, C ;
Luong, TN ;
Simmons, RL ;
DeLano, WL ;
Choong, IC ;
Burdett, MT ;
Flanagan, WM ;
Lee, D ;
Gordon, EM ;
O'Brien, T .
NATURE BIOTECHNOLOGY, 2003, 21 (03) :308-314
[6]   Improving the odds in discriminating "Drug-like" from "Non Drug-like" compounds [J].
Frimurer, TM ;
Bywater, R ;
Nærum, L ;
Lauritsen, LN ;
Brunak, S .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2000, 40 (06) :1315-1324
[7]   Inhibition of voltage-dependent sodium channels by Ro 31-8220, a 'specific' protein kinase C inhibitor [J].
Lingameneni, R ;
Vysotskaya, TN ;
Duch, DS ;
Hemmings, HC .
FEBS LETTERS, 2000, 473 (02) :265-268
[8]   Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings [J].
Lipinski, CA ;
Lombardo, F ;
Dominy, BW ;
Feeney, PJ .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 23 (1-3) :3-25
[9]   Kinase inhibitors: Not just for kinases anymore [J].
McGovern, SL ;
Shoichet, BK .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (08) :1478-1483
[10]   A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening [J].
McGovern, SL ;
Caselli, E ;
Grigorieff, N ;
Shoichet, BK .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (08) :1712-1722